World

Dutch lawmakers condemn U.S. attack on Venezuela

Jan 04, 2026

The Hague [Netherlands], January 4: Several members of the Dutch House of Representatives on Saturday condemned a U.S. attack on Venezuela, which led to the capture of Venezuelan President Nicolas Maduro.
Socialist Party leader Jimmy Dijk wrote on social media platform X that "Trump is bombing boats, drowning people, ports, and now another country." He warned that such military expansion is fueling international instability and endangering lives, stressing that the Netherlands must condemn the attack.
GreenLeft-Labor Party leader Jesse Klaver also denounced what he described as an "illegal attack by the Trump administration on Venezuela," saying it could have serious consequences for the region, including the Caribbean parts of the Kingdom of the Netherlands - Aruba, Bonaire, and Curacao.
Christine Teunissen of the Party for the Animals likewise labeled the action an "illegal attack," noting that it impacts people who are already "in an extremely vulnerable situation." She urged the Dutch cabinet to issue a strong condemnation.
According to Dutch Prime Minister Dick Schoof, the cabinet is closely following developments in the Caribbean and the situation in Venezuela.
Dutch Foreign Minister David Van Weel issued a statement which called on "all parties to prevent further escalation and to comply with international law."
U.S. President Donald Trump said on Saturday that the United States has struck Venezuela and captured its President Nicolas Maduro, who was flown out of the country along with his wife.
Venezuela on Saturday denounced a "military aggression" by the United States, after large explosions were heard and aircraft were seen over the capital Caracas earlier in the day.
Source: Xinhua News Agency

More news

Sirolimus-Coated Balloon Matches Drug-Eluting Stent at One Year in Large International TRANSFORM II Trial

Tampa (Florida) [US], November 2: Sirolimus-coated balloon (SCB) strategy was non-inferior to contemporary everolimus-eluting stents (EES) for Target Lesion Failure (TLF) at 12 months in patients with de novo coronary artery disease. These are the results of the TRANSFORM II randomised trial, presented today as a Late-Breaking Clinical Trial at TCT 2026 and accepted in The Lancet which confirm how MagicTouch Sirolimus Coated Balloon (Concept Medical) matches contemporary best in class stent. Late-breaking results presented at TCT 2026 show an implant-free strategy with MagicTouch Sirolimus Coated Balloon is non-inferior to everolimus-eluting in de novo coronary artery disease.

Nov 02, 2026